These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24587850)

  • 1. Comparison and overview of currently available neurotoxins.
    Walker TJ; Dayan SH
    J Clin Aesthet Dermatol; 2014 Feb; 7(2):31-9. PubMed ID: 24587850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Handling botulinum toxins: an updated literature review.
    Trindade De Almeida AR; Secco LC; Carruthers A
    Dermatol Surg; 2011 Nov; 37(11):1553-65. PubMed ID: 21777338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of botulinum neurotoxins.
    Lowe NJ
    J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New neurotoxins on the horizon.
    Freeman SR; Cohen JL
    Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of botulinum toxin in otorhinolaryngology: an updated review.
    Mandavia R; Dessouky O; Dhar V; D'Souza A
    Clin Otolaryngol; 2014 Aug; 39(4):203-9. PubMed ID: 24930740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxin type B--a rapid wrinkle reducer.
    Jacob CI
    Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A succinct review of botulinum toxin in dermatology; update of cosmetic and noncosmetic use.
    Feily A; Fallahi H; Zandian D; Kalantar H
    J Cosmet Dermatol; 2011 Mar; 10(1):58-67. PubMed ID: 21332916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents.
    Giordano CN; Matarasso SL; Ozog DM
    J Am Acad Dermatol; 2017 Jun; 76(6):1013-1024. PubMed ID: 28522038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons among botulinum toxins: an evidence-based review.
    Klein AW; Carruthers A; Fagien S; Lowe NJ
    Plast Reconstr Surg; 2008 Jun; 121(6):413e-422e. PubMed ID: 18520868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: dosing and dilution.
    Francisco GE
    Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S30-7. PubMed ID: 15448575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS; Pickett A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of botulinum toxins.
    Naumann M; Boo LM; Ackerman AH; Gallagher CJ
    J Neural Transm (Vienna); 2013 Feb; 120(2):275-90. PubMed ID: 23008029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.